We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+14.11%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$944M
AUM Growth
+$119M
Cap. Flow
+$5.3M
Cap. Flow %
0.56%
Top 10 Hldgs %
30.12%
Holding
256
New
19
Increased
59
Reduced
92
Closed
3

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.03M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.6M
3
WAB icon
Wabtec
WAB
+$2.09M
4
MPC icon
Marathon Petroleum
MPC
+$1.55M
5
BA icon
Boeing
BA
+$1.28M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.28M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.12M
3
WFC icon
Wells Fargo
WFC
+$1.43M
4
ABBV icon
AbbVie
ABBV
+$917K
5
FDX icon
FedEx
FDX
+$843K

Sector Composition

Rank Sector Weight
1 Healthcare 19.73%
2 Industrials 14.53%
3 Technology 14.16%
4 Financials 14.05%
5 Energy 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$339B
$10.2M 1.08%
98,094
-1,790
-2% -$174K
RTX icon
27
RTX Corp
RTX
$301B
$9.85M 1.04%
121,368
+1,681
+1% +$128K
BXMT icon
28
Blackstone Mortgage Trust
BXMT
$2.38B
$9.72M 1.03%
281,334
-4,336
-2% -$147K
CELG
29
DELISTED
Celgene Corp
CELG
$9.59M 1.02%
101,604
-3,707
-4% -$324K
HON icon
30
Honeywell
HON
$78B
$9.58M 1.02%
63,944
+3,262
+5% +$456K
WAB icon
31
Wabtec
WAB
$49.3B
$9.46M 1%
128,295
+29,003
+29% +$2.09M
ORCL icon
32
Oracle
ORCL
$423B
$9.37M 0.99%
174,485
+7,239
+4% +$369K
J icon
33
Jacobs Solutions
J
$17B
$9.31M 0.99%
149,759
-181
-0.1% -$10.2K
UNH icon
34
UnitedHealth
UNH
$370B
$8.49M 0.9%
34,337
+19,712
+135% +$5.03M
ABBV icon
35
AbbVie
ABBV
$435B
$7.97M 0.85%
98,953
-11,206
-10% -$917K
PFE icon
36
Pfizer
PFE
$153B
$7.85M 0.83%
194,710
-4,230
-2% -$169K
EMR icon
37
Emerson Electric
EMR
$88.3B
$7.83M 0.83%
114,299
-100
-0.1% -$6.58K
AXP icon
38
American Express
AXP
$230B
$7.81M 0.83%
71,468
-572
-0.8% -$60.1K
PWR icon
39
Quanta Services
PWR
$101B
$7.71M 0.82%
204,240
+50
+0% +$1.75K
PEP icon
40
PepsiCo
PEP
$190B
$7.56M 0.8%
61,691
-239
-0.4% -$27.2K
AGN
41
DELISTED
Allergan plc
AGN
$7.28M 0.77%
49,702
LRCX icon
42
Lam Research
LRCX
$390B
$7.17M 0.76%
400,270
-37,320
-9% -$623K
META icon
43
Meta Platforms (Facebook)
META
$1.51T
$7.16M 0.76%
42,943
+1,578
+4% +$251K
WFC icon
44
Wells Fargo
WFC
$264B
$7.13M 0.76%
147,643
-29,045
-16% -$1.43M
IBM icon
45
IBM
IBM
$224B
$7.12M 0.75%
52,773
-4,521
-8% -$576K
IBB icon
46
iShares Biotechnology ETF
IBB
$9.77B
$7.11M 0.75%
63,614
-300
-0.5% -$32.9K
CRM icon
47
Salesforce
CRM
$158B
$6.76M 0.72%
42,717
+5,279
+14% +$818K
COST icon
48
Costco
COST
$420B
$6.22M 0.66%
25,698
+200
+0.8% +$43.7K
ADP icon
49
Automatic Data Processing
ADP
$108B
$5.82M 0.62%
36,426
-100
-0.3% -$14.5K
VZ icon
50
Verizon
VZ
$196B
$5.65M 0.6%
95,525
+4,361
+5% +$247K

Similar funds

Neville Rodie & Shaw's Q1 2019 Portfolio in Review

As of Q1 2019, Neville Rodie & Shaw held 256 positions worth $944M, up 14% from $824M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q1 2019 filing shows 19 new, 59 increased, 92 reduced and 3 closed positions. Its largest new stake was Marathon Oil Corporation: 30,176 shares worth $505K. The largest sale was JPMorgan Chase, an estimated $2.28M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • Neville Rodie & Shaw's largest Q1 2019 buy was Marathon Oil Corporation: 30,176 shares worth $505K.
  • Neville Rodie & Shaw added most to UnitedHealth in Q1 2019, an estimated $5.03M increase.
  • Neville Rodie & Shaw's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $2.28M.
  • Neville Rodie & Shaw fully exited Shire pic in Q1 2019, selling an estimated $806K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $944M portfolio in Q1 2019.
  • Neville Rodie & Shaw opened 19 new positions and closed 3 in Q1 2019.
  • Neville Rodie & Shaw's portfolio value rose 14% quarter-over-quarter to $944M.

Based on Neville Rodie & Shaw's 13F filing for Q1 2019, filed 8 Apr 2019.